Small bowel adenocarcinoma in Crohn's disease: A case report and review of literature

World Journal of Gastroenterology

Volumn 12, Issue 8, 2006, Pages 1317-1320

  Kronberger, Irmgard E ^a   Graziadei, Ivo W ^a   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Case report; Crohn's disease; Small bowel adenocarcinoma

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CYTARABINE; FLUOROURACIL; FOLINIC ACID; MESALAZINE; METHOTREXATE; METRONIDAZOLE; OXALIPLATIN; PREDNISONE;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RISK; CARCINOMATOUS MENINGITIS; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; FOLLOW UP; GASTROINTESTINAL SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; RARE DISEASE; RISK ASSESSMENT; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CARCINOMA; SURGICAL ANATOMY;

EID: 33645522419     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i8.1317     Document Type: Article

References (60)

1. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis 2004; 10 Suppl 1: S32-S34
2. Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL. IBD and genetics: new developments. Scand J Gastroenterol Suppl 2003; : 63-68
3. Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Joossens S, Vlietinck R, Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol 2004; 99: 299-305
4. Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003; 3: 507-514
5. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 1998; 22: 275-284
6. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18 Suppl 2: 1-5
7. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444-1451
8. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ 2000; 321: 805-808
9. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535
10. Judge TA, Lewis JD, Lichtenstein GR. Colonic dysplasia. and cancer in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002; 12:495-523
11. Barwood N, Platell C. Case report: adenocarcinoma arising in a Crohn's stricture of the jejunum. J Gastroenterol Hepatol 1999; 14:1132-1134
12. Mohan IV, Kurian KM, Howd A. Crohn's disease presenting as adenocarcinoma of the small bowel. Eur J Gastroenterol Hepatol 1998; 10: 431-432
13. Solem CA, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Small intestinal adenocarcinoma in Crohn's disease: a case-control study. Inflamm Bowel Dis 2004; 10: 32-35
14. Jess T, Winther KV, Munkholm. P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004; 19: 287-293
15. Parkin D.M. WSL, Forlay J., Teppo L., Thomas D.B., ed. Age-standardized (world) incidence (per 100,000) and cumulative (0-74) incidence (percent) rates and standard errors. Incidence in Five Continents Vol. VIII, ed. I.S. Publications. Vol. 155.2002, IARC Scientific Publications: Lyon. 549-551
16. AustrianStatistics, Indicence and Mortality of small intestine cancer, Mortality of Crohn's disease 1983 - 2000. 2004, Statistik Austria: Vienna.
17. Koga H, Aoyagi K, Hizawa K, Iida M, Jo Y, Yao T, Oohata Y, Mibu R, Fujishima M. Rapidly and infiltratively growing Crohn's carcinoma of the small bowel: serial radiologic findings and a review of the literature. Clin Imaging 1999; 23: 298-301
18. Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 459-477
19. Nesbit RR Jr, Elbadawi NA, Morton JH, Cooper RA Jr. Carcinoma of the small bowel. A complication of regional enteritis. Cancer 1976; 37: 2948-2959
20. Beachley MC, Lebel A, Lankau CA Jr, Rothman D, Baldi A. Carcinoma of the small intestine in chronic regional enteritis. Am J Dig Dis 1973; 18:1095-1098
21. Michelassi F, Testa G, Pomidor WJ, Lashner BA, Block GE. Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum 1993; 36: 654-661
22. Frank JD, Shorey BA. Adenocarcinoma of the small bowel as a complication of Crohn's disease. Gut 1973; 14: 120-124
23. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001; 91: 854-862
24. Marchetti F, Fazio VW, Ozuner G. Adenocarcinoma arising from a strictureplasty site in Crohn's disease. Report of a case. Dis Colon Rectum 1996; 39:1315-1321
25. Partridge SK, Hodin RA. Small bowel adenocarcinoma at a strictureplasty site in a patient with Crohn's disease: report of a case. Dis Colon Rectum 2004; 47: 778-781
26. Furukawa A, Saotome T, Yamasaki M, Maeda K, Nitta N, Takahashi M, Tsujikawa T, Fujiyama Y, Murata K, Sakamoto T. Cross-sectional imaging in Crohn disease. Radiographics 2004; 24: 689-702
27. Horton KM, Fishman EK. Multidetector-row computed tomography and 3-dimensional computed tomography imaging of small bowel neoplasms: current concept in diagnosis. J Comput Assist Tomogr 2004; 28: 106-116
28. Buckley JA, Siegelman SS, Jones B, Fishman EK. The accuracy of CT staging of small bowel adenocarcinoma: CT/pathologic correlation. J Comput Assist Tomogr 1997; 21: 986-991
29. Chen S, Harisinghani MG, Wittenberg J. Small bowel CT fat density target sign in chronic radiation enteritis. Australas Radiol 2003; 47: 450-452
30. Schreyer AG, Geissler A, Albrich H, Scholmerich J, Feuerbach S, Rogler G, Volk M, Herfarth H. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol 2004; 2: 491-497
31. Zhan J, Xia ZS, Zhong YQ, Zhang SN, Wang LY, Shu H, Zhu ZH. Clinical analysis of primary small intestinal disease: A report of 309 cases. World J Gastroenterol 2004; 10: 2585-2587
32. Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2004; : CD000279
33. Voderholzer WA, Ortner M, Rogalla P, Beinholzl J, Lochs H. Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis. Endoscopy 2003; 35:1009-1014
34. Jungles SL. Video wireless capsule endoscopy: a diagnostic tool for early Crohn's disease. Gastroenterol Nurs 2004; 27: 170-175
35. Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum JR. Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol 1999; 23: 651-655
36. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997; 113: 127-135
37. Petras RE, Mir-Madjlessi SH, Farmer RG. Crohn's disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 1987; 93: 1307-1314
38. Jankowski JA, Bedford FK, Boulton RA, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim YS, Wright NA, Sanders DS. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest 1998; 78: 1155-1167
39. Lashner BA. Risk factors for small bowel cancer in Crohn's disease. Dig Dis Sci 1992; 37:1179-1184
40. Christodoulou D, Skopelitou AS, Katsanos KH, Katsios C, Agnantis N, Price A, Kappas A, Tsianos EV. Small bowel adenocarcinoma presenting as a first manifestation of Crohn's disease: report of a case, and a literature review. Eur J Gastroenterol Hepatol 2002; 14: 805-810
41. Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, Guenel P, Hardell L, Launoy G, Merler E, Merletti F, Stang A. Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European population-based case-control study. Scand J Gastroenterol 2001; 36: 641-646
42. Lightdale CJ, Sternberg SS, Posner G, Sherlock P. Carcinoma complicating Crohn's disease. Report of seven cases and review of the literature. Am J Med 1975; 59: 262-268
43. Church JM, Weakley FL, Fazio VW, Sebek BA, Achkar E, Carwell M. The relationship between fistulas in Crohn's disease and associated carcinoma. Report of four cases and review of the literature. Dis Colon Rectum 1985; 28: 361-366
44. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-1723
45. Sandmeier D, Bouzourene H. Adenocarcinoma in Crohn's disease. Histopathology 2003; 42: 404-405
46. Westaby S, Everett WG, Dick AP. Adenocarcinoma of the small bowel complicating Crohn's disease in a patient treated with azathioprine. Clin Oncol 1977; 3: 377-381
47. Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002; 16: 1225-1232
48. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-1252
49. van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB. Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl 2002; 48-53
50. Lim WC, Hanauer SB. Controversies with aminosalicylates in inflammatory bowel disease. Rev Gastroenterol Disord 2004; 4: 104-117
51. Allgayer H. Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18 Suppl 2:10-14
52. Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996; 8: 1179-1183
53. Ryan BM, Russel MG, Langholz E, Stockbrugger RW. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow. Am J Gastroenterol 2003; 98: 1682-1687
54. Tilg H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W. Infliximab in the treatment of Crohn's disease - a practical approach. Infliximab and chronic Crohn's disease - Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH. Z Gastroenterol 2004; 42: 1256-1263
55. Wenzl HH, Reinisch W, Jahnel J, Stockenhuber F, Tilg H, Kirchgatterer A, Petritsch W. Austrian infliximab experience in Crohns disease: a nationwide cooperative study with long-term follow-up. Eur J Gastroenterol Hepatol 2004; 16: 767-773
56. Dotan I, Yeshurun D, Hallak A, Horowitz N, Tiomny E, Reif S, Halpern Z, Rachmilewitz D. Treatment of Crohn's disease with anti TNF alpha antibodies - the experience in the Tel Aviv Medical Center. Harefuah 2001; 140: 289-293, 368
57. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004; 101: 518-526
58. Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH Jr. Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet 1991; 173: 343-349
59. Hawker PC, Gyde SN, Thompson H, Allan RN. Adenocarcinoma of the small intestine complicating Crohn's disease. Gut 1982; 23: 188-193
60. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum. JR. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002; 45: 1496-1502